Serveur d'exploration Covid (26 mars) - Exploration (Accueil)

Index « Teeft.i » - entrée « Neutralizing »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Neutralization tests < Neutralizing < Neutralizing antibodies  Facettes :

List of bibliographic references indexed by Neutralizing

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
001714 (2006) Yasuko Tsunetsugu-Yokota [Japon] ; Kazuo Ohnishi [Japon] ; Toshitada Takemori [Japon]Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine
001721 (2006) Hongying Mo ; Guangqiao Zeng ; Xiaolan Ren ; Hui Li ; Changwen Ke ; Yaxia Tan ; Chaoda Cai ; Kefang Lai ; Rongchang Chen ; Moira Chan-Yeung [Canada] ; Nanshan ZhongLongitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significance
001783 (2005) Jian-San Zhang [République populaire de Chine] ; Jiang-Ting Chen [République populaire de Chine] ; Yu-Xuan Liu [République populaire de Chine] ; Zhen-Shan Zhang [République populaire de Chine] ; Hong Gao [République populaire de Chine] ; Yan Liu [République populaire de Chine] ; Xu Wang [République populaire de Chine] ; Ye Ning [République populaire de Chine] ; Yu-Fen Liu [République populaire de Chine] ; Qiang Gao [République populaire de Chine] ; Jian-Guo Xu [République populaire de Chine] ; Chuan Qin [République populaire de Chine] ; Xiao-Ping Dong [République populaire de Chine] ; Wei-Dong Yin [République populaire de Chine]A serological survey on neutralizing antibody titer of SARS convalescent sera
001857 (2003) Research Abstract Program of the 21st Annual ACVIM Forum Charlotte, NC, June 4–7, 2003
001881 (2002) Research Abstract Program of the 20th Annual ACVIM Forum Dallas, TX, May 29‐June 1, 2002
001960 (1998) F. M. Fernandez [États-Unis, Argentine] ; M. E. Conner [États-Unis] ; D. C. Hodgins [États-Unis] ; A. V. Parwani [États-Unis] ; P. R. Nielsen [États-Unis] ; S. E. Crawford [Argentine] ; M. K. Estes [Argentine] ; L. J. Saif [États-Unis]Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines
001A96 (1993) Eric M. Vaughn [États-Unis] ; Prem S. Paul [États-Unis]Antigenic and biological diversity among transmissible gastroenteritis virus isolates of swine
001A97 (1993) Christopher W. Olsen [États-Unis]A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination
001B31 (1992) Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
001B32 (1992) Vaccine comprising anti-idiotype antibody conjugate; induces production of neutralizing antibody (human monoclonal antibody, chimeric antibody or FAb, F(Ab′) 2 or Fv fragment) against HIV virus-1
001B37 (1992) Recombinant pox virus containing Morbilli virus DNA; expression of e.g. measles virus haemagglutinin glycoprotein in host for construction of a potential recombinant vaccine against dog distemper virus
001B38 (1992) Recombinant feline corona virus-S protein; expressed as galactokinase fusion protein and useful as reconbinant vaccine, therapeutic and diagnostic agents for feline-infectious-peritonitis virus
001B41 (1992) Nucleic acid constructs, malaria polypeptides and vaccines; recombinant malaria serine-repeat antigen production in yeast for the construction of a recombinant vaccine
001B42 (1992) New gene fragment encoding rabies virus glycoprotein; DNA sequence expression in eukaryote cell culture and application to recombinant vaccine construction
001B45 (1992) Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast
001B49 (1992) Ronald S. Murray [États-Unis] ; Guang-Yun Cai [États-Unis] ; Kristen Hoel [États-Unis] ; J.-Y. Zhang [États-Unis] ; Kenneth F. Soike [États-Unis] ; Gary F. Cabirac [États-Unis]Coronavirus infects and causes demyelination in primate central nervous system
001B53 (1992) Antigen composition comprising PEB1 and/or PEB3 antigen from Campylobacter jejuni ; useful as vaccine and for diagnosis of C. jejuni and Campylobacter coli infections
001B72 (1991) S. Schwender ; H. Imrich ; R. DörriesThe pathogenic role of virus-specific antibody secreting cells in the CNS of rats resistant and susceptible to coronavirus-induced encephalitis
001B78 (1991) C. Cianchetti ; A. L. Fratta ; F. Muntoni ; M. G. MarrosuIntraventricular recombinant alpha-interferon in subacute sclerosing panencephalitis
001C51 (1989) Abstracts of Papers Presented at the Session of the Virology Section of the Deutsche Gesellschaft für Hygiene und Mikrobiologie, Marburg, February 23-25, 1989
001C99 (1988) Abstracts of Papers Presented at the Session of the Virology Section of the Deutsche Gesellschaft für Hygiene und Mikrobiologie, Martinsried, March 25–28, 1987

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Neutralizing" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Neutralizing" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Neutralizing
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021